Some deleterious mutations in RASAL1 were reported in follicular thyroid cancer (FTC) and anaplastic thyroid cancer (ATC) with in vitro confirmation of their oncogenic consequences, identifying RASAL1 for the first time as a tumor suppressor gene in a human cancer (thyroid cancer) [8, 18]. Here, RASAL1 is linked to neoplasm.